首页> 外国专利> Derivatives of quinolein - 2 (1H) - one and dihidroquinolein - 2 (1H) - One, its preparation and its application in Therapeutics.

Derivatives of quinolein - 2 (1H) - one and dihidroquinolein - 2 (1H) - One, its preparation and its application in Therapeutics.

机译:喹诺酮-2(1H)-一和二氢喹啉-2(1H)-一的衍生物,其制备方法及其在治疗学中的应用。

摘要

Formula compound (I), in which the dial line can be an additional link, G represents (II) at 3 or 4, M = 2-4, Z represents a denitorogeno atom or a group of - CH -,R1 and R2 each independently represent one another, a hydrogen or halogen atom, an amino group, hydroxy, nitro, cyano, (C1-C6) alkyl, (C1-C6) alkoxy, trifluoromethyl, trifluoromethoxy, -COOH, - COOR4, -CONH2, -CONHR4, -CONR4R5, -SR4, -SO2R4, -NHCOR4, -NHSO2R4, -N (R4) 2, R3 represents a hydrogen atom, a (C1-C4) alkyl group, - (CH2) 7OH, - (CH2) pNH2, - (CH2) n COOH, - (CH2) nCOOR4, -CH2) nCN, - (CH2) n-tetrazolyl, - (CH2) nCONH2, - (CH2) nCONHOH, - (CH2) pSH, - (CH2) nSO3H, - (CH2) nSO2NH2, - (CH2) nSO2NHR4, - (CH2) nSO2NR4R5, - (CH2) nCONHR4, - (CH2) pNHSO2R4, - (CH2) pNHCOR4, - (CH2) pOCOR R4 and R5 are each a (C1-C4) alkyl group, n = 1 to 4,P = 2-4 and a represent a benzo group that may or may not be replaced for the treatment and production of an effective drug to treat and prevent various forms of diseases, such as heart disease, kidney disease, eye disease, encephalopathy or ischemia and heart failure of lower members, Myocardial infarction, elangor, thrombus (alone or related to thrombus)Arteritis, intermittent claudication, the recovery disorder after angioplasty, and various diseases related to osteoporosis, microcirculation system disorder or pulmonary dysfunction. It can also be used to treat and prevent hypertension, vein, lung, portal, kidney or eyeball, and coronary or peripheral vascular infection.
机译:式化合物(I),其中拨号线可以是一个附加链接,G表示3或4处的(II),M = 2-4,Z表示树枝状生成原子或-CH-,R1和R2各自组成的基团独立地彼此代表氢或卤素原子,氨基,羟基,硝基,氰基,(C1-C6)烷基,(C1-C6)烷氧基,三氟甲基,三氟甲氧基,-COOH,-COOR4,-CONH2,-CONHR4 ,-CONR4R5,-SR4,-SO2R4,-NHCOR4,-NHSO2R4,-N(R4)2,R3代表氢原子,(C1-C4)烷基,-(CH2)7OH,-(CH2)pNH2, -(CH2)n COOH,-(CH2)nCOOR4,-CH2)nCN,-(CH2)n-四唑基,-(CH2)nCONH2,-(CH2)nCONHOH,-(CH2)pSH,-(CH2)nSO3H, -(CH2)nSO2NH2,-(CH2)nSO2NHR4,-(CH2)nSO2NR4R5,-(CH2)nCONHR4,-(CH2)pNHSO2R4,-(CH2)pNHCOR4,-(CH2)pOCOR R4和R5均为(C1- C4)烷基,n = 1-4,P = 2-4,并且a表示可以取代或可以不取代的苯甲酸酯基,用于治疗和生产有效的药物,以治疗和预防各种形式的疾病,例如耳聋下肢疾病,肾脏疾病,眼病,脑病或局部缺血和心力衰竭,心肌梗塞,水肿,血栓(单独或与血栓有关),关节炎,间歇性lau行,血管成形术后的恢复障碍以及与骨质疏松症相关的各种疾病,微循环系统障碍或肺功能障碍。它也可以用于治疗和预防高血压,静脉,肺,门静脉,肾脏或眼球以及冠状或外周血管感染。

著录项

  • 公开/公告号AR012094A1

    专利类型

  • 公开/公告日2000-09-27

    原文格式PDF

  • 申请/专利权人 SYNTHELABO;

    申请/专利号AR1998P101209

  • 发明设计人

    申请日1998-03-18

  • 分类号C07D491/048;C07D401/12;C07D471/04;A61K31/495;A61K31/505;C07F9/40;

  • 国家 AR

  • 入库时间 2022-08-22 01:57:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号